Literature DB >> 3878878

Serological and clinical remission in systemic lupus erythematosus.

C A Heller, P H Schur.   

Abstract

The frequency of a combined clinical and serological remission in patients with systemic lupus erythematosus (SLE) was examined. Thirteen (4%) of 305 patients had both a seroconversion from a positive to a negative ANA and became asymptomatic in respect to their SLE. These remissions lasted from 6 months to 13 years. It is not clear what role, if any, therapy played in these remissions. Nevertheless, these remissions provided hope for the patients and their physicians.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878878

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

1.  Factors associated with remission in patients with systemic lupus erythematosus: new insights into a desirable state.

Authors:  Jorge Romo-Tena; Roberto Reyna-de la Garza; Isaac Bartnicki-Navarrete; Jorge Alcocer-Varela; Diana Gómez-Martin
Journal:  Clin Rheumatol       Date:  2018-07-28       Impact factor: 2.980

2.  Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort.

Authors:  Noémi Györi; Ioanna Giannakou; Katerina Chatzidionysiou; Laurence Magder; Ronald F van Vollenhoven; Michelle Petri
Journal:  Lupus Sci Med       Date:  2017-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.